56
Participants
Start Date
April 30, 2009
Primary Completion Date
July 31, 2011
Study Completion Date
September 30, 2011
Azixa
3.3 mg/m2 of Azixa administered by intravenous infusion over 2 hours once weekly for 3 consecutive weeks every 4 weeks (1 cycle = 4 weeks)
Columbia University, New York
Northwestern University, Chicago
Barrow Neurological Institute, Phoenix
Cedars-Sinai Medical Center, Los Angeles
Stanford University, Stanford
SCCA/University of Washington, Seattle
Tufts Medical Center, Boston
Lahey Clinic, Burlington
University of Massachusettes, Worcester
Darthmouth -Hitchcock Medical Center, Lebanon
Lead Sponsor
Myrexis Inc.
INDUSTRY